Bio-Path (BPTH) Institutional Ownership $0.80 +0.01 (+1.57%) (As of 10:08 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Bio-Path (NASDAQ:BPTH)CurrentInstitutional OwnershipPercentage5.74%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$194KNumber ofInstitutional Sellers(last 12 months)0 Get BPTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bio-Path stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BPTH Institutional Buying and Selling by Quarter Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Bio-Path Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC97,000$194K0.0%N/A4.663% 11/7/2022Virtu Financial LLC12,090$39K0.0%N/A0.169% 11/7/2022 Mount Yale Investment Advisors LLC25,350$81K0.0%N/A0.354% 2/10/2022 Bailard Inc.33,521$126K0.0%N/A0.468% 8/16/2021 State Street Corp12,133$81K0.0%N/A0.174% 8/13/2021 Northern Trust Corp17,744$119K0.0%N/A0.255% 8/13/2021 Geode Capital Management LLC65,353$435K0.0%+15.5%0.939% 8/13/2021 Vanguard Group Inc.218,992$1.46M0.0%+76.2%3.146% 8/12/2021 Dimensional Fund Advisors LP28,148$188K0.0%+58.8%0.404% 5/21/2021 Citadel Advisors LLC20,591$145K0.0%N/A0.296% 5/18/2021 Citadel Advisors LLC20,591$145K0.0%N/A0.296% 5/14/2021 Dimensional Fund Advisors LP17,725$124K0.0%N/A0.255% 5/13/2021 Renaissance Technologies LLC73,800$518K0.0%-4.9%1.062% 5/12/2021 Geode Capital Management LLC56,590$397K0.0%+65.5%0.814% 2/24/2021Virtu Financial LLC33,236$116K0.0%N/A0.478% 2/10/2021 Renaissance Technologies LLC77,587$272K0.0%+27.0%1.708% (Data available from 1/1/2016 forward) BPTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BPTH shares? During the previous two years, the following institutional investors and hedge funds held shares of Bio-Path shares: Armistice Capital LLC ($194K).Learn more on BPTH's institutional investors. What percentage of Bio-Path stock is owned by institutional investors? 5.74% of Bio-Path stock is owned by institutional investors. Learn more on BPTH's institutional investor holdings. Which institutional investors have been buying Bio-Path stock? The following institutional investors have purchased Bio-Path stock in the last 24 months: Armistice Capital LLC ($97K). How much institutional buying is happening at Bio-Path? Institutional investors have bought a total of 97,000 shares in the last 24 months. This purchase volume represents approximately $194K in transactions. Related Companies SNOA Major Shareholders MBRX Major Shareholders COEP Major Shareholders ADXN Major Shareholders GLTO Major Shareholders BCLI Major Shareholders CANF Major Shareholders ABVC Major Shareholders GTBP Major Shareholders SYRS Major Shareholders This page (NASDAQ:BPTH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Path Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Path With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.